Enhancement of Cancer Research at Clark Atlanta University
Enhancement of Cancer Research at Clark Atlanta University
批准号:
10361227
负责人:
DAQING WU
金额:
$154.61万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1997
资助国家:
美国
项目状态:
已结题
起止时间:
1997-06-01 至 2024-02-29
关键词:
AffectAfrican AmericanAgeAnimal ExperimentationAreaAwarenessBasic ScienceBehavioralBiologicalBiological SciencesCaliberCancer BiologyCaucasiansCellular biologyChemistryCommunitiesCommunity OutreachCore FacilityDevelopmentDiseaseEarly DiagnosisEarly treatmentEducationEducational ActivitiesEquipmentFacultyFaculty RecruitmentFundingFuture GenerationsIncidenceInformation DisseminationInfrastructureInstitutionInternationalLaboratoriesLaboratory ResearchMalignant NeoplasmsMalignant neoplasm of prostateMentorsMissionModernizationMolecularMolecular BiologyMolecular and Cellular BiologyNCI Center for Cancer ResearchPilot ProjectsPostdoctoral FellowPreventionPrivatizationProgram DevelopmentProstate Cancer therapyResearchResearch ActivityResearch InfrastructureResearch PersonnelResearch Project GrantsResearch SupportResearch TrainingRiskSchoolsScientistStudentsTeacher Professional DevelopmentTherapeuticTimeTrainingTraining and EducationUnited States National Institutes of HealthUniversitiesadvanced diseaseanticancer researchbasebiological researchcancer cellcancer therapycertificate programcohesioncombatcommunity based researchcommunity engagementdrug discoverygraduate studenthigher educationinfrastructure developmentinterestmembermenmortalitynext generationoutreach programprogram disseminationprogramsprostate cancer progressionracial and ethnicracial diversityrecruitresearch and developmentsocioeconomicstenure tracktherapeutic developmentundergraduate student
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Summary
Clark Atlanta University (CAU) is a comprehensive, private, urban, coeducational institution of higher education
with a predominantly African-American heritage. It offers undergraduate, graduate, and professional degrees as
well as certificate programs to students of diverse racial, ethnic, and socioeconomic backgrounds. The Center
for Cancer Research and Therapeutic Development (CCRTD) was established at CAU in 1999 with direct
support from the NIH/RCMI program. CCRTD faculty was derived from the Departments of Biological Sciences,
Chemistry and School of Education with research interests in cancer biology, drug discovery and behavioral
aspects of cancer. In 2004, we decided to build a comprehensive research and educational program which will
focus on prostate cancer and its impact in the African-American community. In 2005, the Center was designated
as CAU's University-wide Center of Excellence to a) develop a core group of internationally known scientists,
that will carry-out highly productive basic research in cancer cell biology and molecular biology and contribute in
the development of successful therapeutic strategies to combat cancer., b) train undergraduate and graduate
students and post-doctoral fellows in the area of cancer biology and, hence, help develop the future generation
of African-American scientists of the highest caliber. And c) establish an educational program to increase
awareness for prevention, early detection and treatment of cancers, especially those which disproportionately
affect the African-American community. As a consequence of targeted recruitment of faculty and staff over the
past 12 years, CCRTD is currently one of the largest centers of its kind in the nation with a unique and
comprehensive program to combat prostate cancer. We recruited 9 tenure-track faculty members with
established expertise in the area of cell and molecular biology of cancer. They established their research
programs at CCRTD which focus on understanding molecular mechanisms in the development and progression
of prostate cancer and also on the biological basis of higher incidence and development of more advanced
disease at an earlier age in African-American men. In order to provide state-of-the art research infrastructure to
carry out cutting-edge cell and molecular biology research, CCRTD has developed research core laboratories to
support research activities of faculty, staff and students. These core facilities have undergone significant
expansion throughout the past several years. We have also been actively engaged in the research training and
education of both undergraduate and graduate students in the area of prostate cancer biology. Our community
outreach has established dynamic educational and community based research programs which serve the
African-American community in the metro Atlanta and beyond. The current proposal seeks to expand and
enhance current research and educational activities at CCRTD and will focus on three specific aims. First aim
will expand and enhance current research programs in prostate cancer and professional development
by supporting three research projects and developing a pilot project program to support junior faculty,
investigators and postdoctoral scientists. The second aim will attempt to restructure and modernize research
core facilities by consolidating current 8 core research laboratories into 5 core laboratories to create a more
efficient research infrastructure. we will also establish a new animal research core laboratory acquire new
equipment to upgrade the current research core laboratories. The purpose of the aim 3 will be to create an
integrated infrastructure for development of a comprehensive program for dissemination of information and
community engagement which will involve local, national and global communities. We will use our current
strengths in professional development programs in basic research area, and in the community outreach and
educational programs to create this new infrastructure.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Targeting chemoresistant prostate cancer with novel EED inhibitors
-
批准号:10444602
-
项目类别:
-
资助金额:$54.32万
-
财政年份:2022
-
负责人:DAQING WU
-
依托单位:
Targeting chemoresistant prostate cancer with novel EED inhibitors
-
批准号:10590661
-
项目类别:
-
资助金额:$46.34万
-
财政年份:2022
-
负责人:DAQING WU
-
依托单位:
Diversity Supplement: Targeting chemoresistant prostate cancer with novel EED inhibitors
-
批准号:10747516
-
项目类别:
-
资助金额:$5.92万
-
财政年份:2022
-
负责人:DAQING WU
-
依托单位:
Small-molecule therapy for metastatic castration-resistant prostate cancer
-
批准号:10325729
-
项目类别:
-
资助金额:$100.78万
-
财政年份:2017
-
负责人:DAQING WU
-
依托单位:
Small-molecule therapy for metastatic castration-resistant prostate cancer
-
批准号:10472020
-
项目类别:
-
资助金额:$92.74万
-
财政年份:2017
-
负责人:DAQING WU
-
依托单位:
Small-molecule therapy for metastatic prostate cancer
-
批准号:9407585
-
项目类别:
-
资助金额:$22.5万
-
财政年份:2017
-
负责人:DAQING WU
-
依托单位:
A Dietary Supplement As Adjunct Therapy In Castration-Resistant Prostate Cancer
-
批准号:8834755
-
项目类别:
-
资助金额:$16.1万
-
财政年份:2015
-
负责人:DAQING WU
-
依托单位:
EPLIN as a Molecular Target of Genistein in Preventing Prostate Cancer Metastasis
-
批准号:8854250
-
项目类别:
-
资助金额:$10.38万
-
财政年份:2012
-
负责人:DAQING WU
-
依托单位:
EPLIN as a Molecular Target of Genistein in Preventing Prostate Cancer Metastasis
-
批准号:8386046
-
项目类别:
-
资助金额:$20.34万
-
财政年份:2012
-
负责人:DAQING WU
-
依托单位:
EPLIN as a Molecular Target of Genistein in Preventing Prostate Cancer Metastasis
-
批准号:8507638
-
项目类别:
-
资助金额:$5.56万
-
财政年份:2012
-
负责人:DAQING WU
-
依托单位:
Enhancement of Cancer Research at Clark Atlanta University
-
批准号:10376107
-
项目类别:
-
资助金额:$11.52万
-
财政年份:1997
-
负责人:DAQING WU
-
依托单位:
Enhancement of Cancer Research at Clark Atlanta University
-
批准号:10619518
-
项目类别:
-
资助金额:$272.61万
-
财政年份:1997
-
负责人:DAQING WU
-
依托单位:
海外基金